Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$1.6B |
| 2 |
American Express
AXP
|
+$398M |
| 3 |
Capital One
COF
|
+$151M |
| 4 |
Apollo Global Management
APO
|
+$111M |
| 5 |
DFS
Discover Financial Services
DFS
|
+$109M |
Top Sells
| 1 |
Apple
AAPL
|
+$1.16B |
| 2 |
Microsoft
MSFT
|
+$873M |
| 3 |
Amazon
AMZN
|
+$403M |
| 4 |
NVIDIA
NVDA
|
+$356M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$283M |
Sector Composition
| 1 | Technology | 30.21% |
| 2 | Healthcare | 13.75% |
| 3 | Consumer Discretionary | 12.04% |
| 4 | Industrials | 9.22% |
| 5 | Communication Services | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Acadia Realty Trust
AKR
$2.64B
| $2.98M | ﹤0.01% |
207,200
+2,300
| +1% | +$33.1K |
|
|
XHR
1627
Xenia Hotels & Resorts
XHR
$1.41B
| $2.98M | ﹤0.01% |
242,080
-3,700
| -2% | -$45.5K |
|
1628
NBT Bancorp
NBTB
$2.27B
| $2.97M | ﹤0.01% |
93,400
+900
| +1% | +$28.7K |
|
|
LTC
1629
LTC Properties
LTC
$1.67B
| $2.97M | ﹤0.01% |
90,062
+2,600
| +3% | +$85.9K |
|
1630
PDF Solutions
PDFS
$765M
| $2.97M | ﹤0.01% |
65,800
+1,300
| +2% | +$58.6K |
|
|
RDFN
1631
DELISTED
Redfin
RDFN
| $2.97M | ﹤0.01% |
238,900
+27,600
| +13% | +$343K |
|
1632
Under Armour
UAA
$2.08B
| $2.97M | ﹤0.01% |
410,900
+3,600
| +0.9% | +$26K |
|
1633
Celldex Therapeutics
CLDX
$1.62B
| $2.97M | ﹤0.01% |
87,400
+6,000
| +7% | +$204K |
|
1634
Astrana Health
ASTH
$1.38B
| $2.96M | ﹤0.01% |
93,744
+8,100
| +9% | +$256K |
|
1635
Levi Strauss
LEVI
$8.67B
| $2.95M | ﹤0.01% |
204,400
+5,900
| +3% | +$85.1K |
|
1636
Procept Biorobotics
PRCT
$2.07B
| $2.94M | ﹤0.01% |
83,100
+58,900
| +243% | +$2.08M |
|
1637
Catalyst Pharmaceutical
CPRX
$2.44B
| $2.94M | ﹤0.01% |
218,500
+5,100
| +2% | +$68.5K |
|
1638
Xencor
XNCR
$613M
| $2.94M | ﹤0.01% |
117,600
-5,300
| -4% | -$132K |
|
|
ALEX
1639
Alexander & Baldwin
ALEX
$1.34B
| $2.94M | ﹤0.01% |
158,020
+1,400
| +0.9% | +$26K |
|
1640
Triumph Financial, Inc.
TFIN
$1.4B
| $2.93M | ﹤0.01% |
48,300
-1,800
| -4% | -$109K |
|
1641
Northwest Bancshares
NWBI
$1.83B
| $2.93M | ﹤0.01% |
276,600
+16,200
| +6% | +$172K |
|
|
TWO
1642
Two Harbors Investment
TWO
$1.05B
| $2.92M | ﹤0.01% |
210,488
+2,500
| +1% | +$34.7K |
|
1643
LeMaitre Vascular
LMAT
$2.09B
| $2.92M | ﹤0.01% |
43,400
+700
| +2% | +$47.1K |
|
|
CIM
1644
Chimera Investment
CIM
$1.15B
| $2.91M | ﹤0.01% |
168,227
+1,500
| +0.9% | +$26K |
|
|
JOYY
1645
JOYY Inc. American Depositary Shares
JOYY
$3.21B
| $2.91M | ﹤0.01% |
94,716
-60,792
| -39% | -$1.87M |
|
|
DEA
1646
Easterly Government Properties
DEA
$1.07B
| $2.9M | ﹤0.01% |
80,124
+5,640
| +8% | +$204K |
|
1647
Federal Agricultural Mortgage
AGM
$2.15B
| $2.9M | ﹤0.01% |
20,181
+200
| +1% | +$28.7K |
|
|
DICE
1648
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $2.9M | ﹤0.01% |
62,400
-4,500
| -7% | -$209K |
|
1649
Liberty Latin America Class C
LILAK
$1.53B
| $2.9M | ﹤0.01% |
336,217
+21,800
| +7% | +$188K |
|
1650
Iovance Biotherapeutics
IOVA
$821M
| $2.9M | ﹤0.01% |
411,656
+156,100
| +61% | +$1.1M |
|